Concepedia

Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib

Ila Tamaskar, Ronald M. Bukowski, Paul Elson, Adriana G. Ioachimescu, L. Wood, Robert Dreicer, Tarek Mekhail, J. Garcia, Brian I. Rini

Annals of Oncology · 2007 · 147 citations · 10 references

DOI

Concepts

References

10

Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma

Bernard Escudier, Tim Eisen, Walter M. Stadler et al. · New England Journal of Medicine · 2007 · 4.8K citations · Full text

, , +11

In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship.

Dirk B. Mendel, Alexander Laird, Xiaohua Xin et al. · PubMed · 2003 · 2K citations

, , +15

Phase II Placebo-Controlled Randomized Discontinuation Trial of Sorafenib in Patients With Metastatic Renal Cell Carcinoma

Mark J. Ratain, Tim Eisen, Walter M. Stadler et al. · Journal of Clinical Oncology · 2006 · 1K citations · Full text

, , +12

BAY 43-9006 Inhibition of Oncogenic RET Mutants

Francesca Carlomagno, Suresh Anaganti, Teresa Guida et al. · JNCI Journal of the National Cancer Institute · 2006 · 471 citations · Full text

, , +17

Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains.

Masahide Takahashi, Y Buma, Takashi Iwamoto et al. · PubMed · 1988 · 442 citations

, , +15